Showing posts with label BRAF inhibitor (dabrafenib) and MEK inhibitor (trametinib). Show all posts
Showing posts with label BRAF inhibitor (dabrafenib) and MEK inhibitor (trametinib). Show all posts
Monday, June 1, 2015

New triple combination therapy shows promise in controlling advanced melanoma

›
Results of a new study by UCLA researchers has found that a groundbreaking new triple combination therapy shows promising signs of more ef...